About Allergy Therapeuti (OTCMKTS:AGYTF)
Allergy Therapeutics plc, a specialty pharmaceutical company, focusing on allergy vaccination primarily in Europe. The companys primary flagship products consist of the Pollinex Quattro for the treatment of allergic conditions; and monophosphoryl-lipid A, a substance that enhances the immune response to an antigen or allergen. It offers sublingual product, including Oralvac Compact; Venomil product, which is used for the wasp and bee treatment; probiotic products, such as Kallergen-Th, ATI Prob, and Pollagen; Acarovac Plus, a novel tyrosine-adsorbed, modified-allergen product developed for treatment of perennial mite allergy; and DAP, a product for use in the diagnosis of type I or immediate hypersensitivity to benzyl penicillin and related antibiotics (beta lactams) by means of cutaneous tests (prick and intradermal). It is also developing products based on synbiotics that are special formulations of prebiotics and probiotics, such as Kallergen Th and SynGut; Polyvac, a peanut VLP adjuvanted specific immunotherapy; Acarovac Plus and Acarovac MPL that are next generation products for dust mite immunotherapy; and G102, G204, G205, and G306, as well as PQBirch 301 and PQBirch 204 that are subcutaneous immunotherapies, which are in various development phases. The company markets its products in injectable and sublingual formats under various brands. Allergy Therapeutics plc was founded in 1934 and is based in Worthing, the United Kingdom.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Annual Sales$71.98 million
Price / Sales3.53
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Allergy Therapeuti (OTCMKTS:AGYTF) Frequently Asked Questions
What is Allergy Therapeuti's stock symbol?
Allergy Therapeuti trades on the OTCMKTS under the ticker symbol "AGYTF."
Who are some of Allergy Therapeuti's key competitors?
Some companies that are related to Allergy Therapeuti include Cascadian Therapeutics (CASC), Natera (NTRA), PetIQ (PETQ), Concert Pharmaceuticals (CNCE), Arrowhead Pharmaceuticals (ARWR), Mesoblast (MESO), RadNet (RDNT), Civitas Solutions (CIVI), Zealand Pharma A/S - American Depositary Shares (ZEAL), SIGA Technologies (SIGA), Aduro BioTech (ADRO), Zealand Pharma A/S (ZLDPF), Sinovac Biotech (SVA), ChemoCentryx (CCXI), Stemline Therapeutics (STML), Pharma Mar (PHMMF), Corium International (CORI) and Accuray (ARAY).
How do I buy Allergy Therapeuti stock?
Shares of Allergy Therapeuti can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Allergy Therapeuti's stock price today?
One share of Allergy Therapeuti stock can currently be purchased for approximately $0.43.
How big of a company is Allergy Therapeuti?
Allergy Therapeuti has a market capitalization of $253.82 million and generates $71.98 million in revenue each year. Allergy Therapeuti employs 440 workers across the globe.
How can I contact Allergy Therapeuti?
Allergy Therapeuti's mailing address is Dominion Way West Sussex, Worthing X0, BN14 8SA. The company can be reached via phone at 44-19-0384-4700.
MarketBeat Community Rating for Allergy Therapeuti (AGYTF)MarketBeat's community ratings are surveys of what our community members think about Allergy Therapeuti and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Allergy Therapeuti (OTCMKTS:AGYTF) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Earnings History for Allergy Therapeuti (OTCMKTS:AGYTF)
No earnings announcements for this company have been tracked by MarketBeat.com
Allergy Therapeuti (OTCMKTS:AGYTF) Earnings Estimates
Current Year EPS Consensus Estimate: $-0.02 EPS
Next Year EPS Consensus Estimate: $-0.01 EPS
Dividend History for Allergy Therapeuti (OTCMKTS:AGYTF)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Allergy Therapeuti (OTCMKTS AGYTF)
No insider trades for this company have been tracked by MarketBeat.com
Allergy Therapeuti (OTCMKTS AGYTF) News Headlines
Allergy Therapeuti (OTCMKTS:AGYTF) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Allergy Therapeuti (OTCMKTS AGYTF) Stock Chart for Tuesday, February, 20, 2018